To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Bioo Scientific’s Toxicity Assay Kits Increase the Efficiency of Drug Development
Read time: Less than a minute
Bioo Scientific has announced the launch of its MaxDiscovery™ Toxicity Assay Kits. These kits monitor in vivo toxicity by measuring liver and heart function in serum samples. They provide simple colorimetric determination of well-characterized functional markers of for liver and heart.
According to Company, the kits are ideal tools to monitor toxic effects caused by administration of siRNA, DNA plasmids, transfection agents or other therapeutic treatments during preclinical studies.
The assays can be used in a range of mammals, including mice and rats, providing a tool to assess and reduce the toxicity of drugs formulations and to improve drug delivery methods.
According to Dr Joe Krebs, Director of Protein Chemistry and Engineering at Bioo Scientific, “MaxDiscovery™ Toxicity kits are designed to provide researchers with rapid, cost-effective tools required to address the escalating challenges of drug development in today's competitive landscape.”
Assays are available for alanine transaminase, aspartate transminase, alkaline phosphatase, lactate dehydrogenase, cholesterol, and creatine kinase.
According to Company, the kits are ideal tools to monitor toxic effects caused by administration of siRNA, DNA plasmids, transfection agents or other therapeutic treatments during preclinical studies.
The assays can be used in a range of mammals, including mice and rats, providing a tool to assess and reduce the toxicity of drugs formulations and to improve drug delivery methods.
According to Dr Joe Krebs, Director of Protein Chemistry and Engineering at Bioo Scientific, “MaxDiscovery™ Toxicity kits are designed to provide researchers with rapid, cost-effective tools required to address the escalating challenges of drug development in today's competitive landscape.”
Assays are available for alanine transaminase, aspartate transminase, alkaline phosphatase, lactate dehydrogenase, cholesterol, and creatine kinase.
